AXL is a logical molecular target in head and neck squamous cell carcinoma

PURPOSE: Head and neck squamous cell carcinoma (HNSCC) represents the eighth most common malignancy worldwide. Standard of care treatments for HNSCC patients include surgery, radiation and chemotherapy. Additionally, the anti-epidermal growth factor receptor (EGFR) monoclonal antibody cetuximab is o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Brand, Toni M., Iida, Mari, Stein, Andrew P., Corrigan, Kelsey L., Braverman, Cara M., Coan, John, Pearson, Hannah E., Bahrar, Harsh, Fowler, Tyler L., Bednarz, Bryan P., Saha, Sandeep, Yang, David, Gill, Parkash S., Lingen, Mark W., Saloura, Vassiliki, Villaflor, Victoria M., Salgia, Ravi, Kimple, Randall J., Wheeler, Deric L.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5032632/
https://ncbi.nlm.nih.gov/pubmed/25767293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-2648
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados